Ajith Welihinda

Current

• Senior Scientist, Preclinical Development at Theracos, Inc.

Past

• Senior Scientist at Sangstat Medical Corporation (wholly-owned subsidiary of Genzyme Corporation)
• Principal Scientist at Galileo Pharmaceuticals Inc.
• Research Scientist at University of Michigan

1 more...

Education

• University of Michigan Medical School
• Medical College of Ohio
• Dalhousie University

Connections

46 connections

Industry

Pharmaceuticals

Ajith Welihinda’s Summary

• DynamicPh.D. scientist with 9 years of experience in biopharmaceutical industry developing, validating and utilizing assays to support SAR and to evaluate side effect liability of small molecules and peptides.

• Experience in many therapeutic areas – Diabetes, inflammation, cardiovascular, ischemia

• Comprehensive knowledge of drug discovery process from target evaluation to lead selection.

• Demonstrated success in initiating and leading research and development projects/programs from the ground up.

Ajith Welihinda’s Specialties:

• Drug discovery and development, in vitro pharmacology, toxicology and metabolism, mechanism of action

• Target evaluation, target deconvolution, screening, lead selection

• Small molecules, peptides

• Ex-vivo, cell-based, enzyme, receptor binding, GPCR and qRT-PCR assay development and validation

• Cloning, protein expression, stable cell line creation, primary cell isolation

• TR-FRET, FP, luminescence, fluorescence, SPA, microscopy